PDCD1 and colorectal cancer: Among the MSS colorectal cancers, tumors with ARID1A mutations showed higher expression of immune-related molecules (PD-1, cytotoxic T-lymphocyte antigen 4 (CTLA4)) and cytotoxic T cell infiltration compared to the ARID1A wild type [44].